FDA Approves Cabozantinib for Adults and Paediatric Patients 12 Years of Age and Older with pNET and epNET By Ogkologos - April 18, 2025 458 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the CABINET study Source RELATED ARTICLESMORE FROM AUTHOR ESMO’s Special Consultative Status with United Nations Economic and Social Council (UN ECOSOC) Confirmed Until 2028 EMA Recommends Extension of Indications for Selumetinib ESMO Calls for Urgent Changes to the in Vitro Diagnostic Medical Devices Regulation (IVDR) in Order to Safeguard Cancer Research in Europe MOST POPULAR EMA Publishes Guidance to Provide Key Methods and Good Regulatory Practices... November 8, 2021 New on NCI’s Websites for December 2020 December 31, 2020 Shelter Puppies Got A Private Tour Of The Georgia Aquarium March 31, 2020 New Radiation Therapy Won’t Leave Breast Cancer Patients with Unwanted Tattoo... September 13, 2019 Load more HOT NEWS Boy Shaves Head To Support Friend Going Through Cancer 10 Tips for National Cancer Prevention Month Detecting multiple cancers with a ‘simple’ blood test: Where are we? Cancer in My Community: How People With Cancer Access Care in...
